叶酸和维生素B12缺乏症与正常细胞性贫血的关系。

Tatsuya Bando, Masutaka Tokuda, Itsuro Katsuda, Nobuhiko Emi, Akihiro Tomita
{"title":"叶酸和维生素B12缺乏症与正常细胞性贫血的关系。","authors":"Tatsuya Bando,&nbsp;Masutaka Tokuda,&nbsp;Itsuro Katsuda,&nbsp;Nobuhiko Emi,&nbsp;Akihiro Tomita","doi":"10.20407/fmj.2022-016","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Deficiencies in folate (FA) and vitamin B12 (VB12) are causes of macrocytic anemia. However, in clinical practice, FA and/or VB12 deficiency can occur in patients with normocytic anemia. This study aimed to determine the prevalence of FA/VB12 deficiency in patients with normocytic anemia and the importance of vitamin replacement therapy in these patients.</p><p><strong>Methods: </strong>We retrospectively reviewed electronic medical record information of patients whose hemoglobin and serum FA/VB12 concentrations were measured at the Department of Hematology (N=1,388) and other departments (N=1,421) of Fujita Health University Hospital.</p><p><strong>Results: </strong>In the Hematology Department, 530 (38%) patients showed normocytic anemia. Of these, 49 (9.2%) had FA/VB12 deficiency. Twenty of 49 (41%) patients had some hematological malignancies and 27 (55%) had benign hematological disorders. Of the nine patients who received vitamin replacement therapy, one showed a partial improvement in the hemoglobin concentration of ≥1 g/dL.</p><p><strong>Conclusions: </strong>In the clinical setting, the measurement of FA/VB12 concentrations in patients with normocytic anemia may be useful. Replacement therapy may be a treatment option to consider in patients with low FA/VB12 concentrations. However, physicians need to pay attention to the presence of background diseases, and the mechanisms of this situation require further investigation.</p>","PeriodicalId":33657,"journal":{"name":"Fujita Medical Journal","volume":"9 2","pages":"134-141"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206897/pdf/","citationCount":"0","resultStr":"{\"title\":\"Involvement of folate and vitamin B12 deficiency in patients with normocytic anemia.\",\"authors\":\"Tatsuya Bando,&nbsp;Masutaka Tokuda,&nbsp;Itsuro Katsuda,&nbsp;Nobuhiko Emi,&nbsp;Akihiro Tomita\",\"doi\":\"10.20407/fmj.2022-016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Deficiencies in folate (FA) and vitamin B12 (VB12) are causes of macrocytic anemia. However, in clinical practice, FA and/or VB12 deficiency can occur in patients with normocytic anemia. This study aimed to determine the prevalence of FA/VB12 deficiency in patients with normocytic anemia and the importance of vitamin replacement therapy in these patients.</p><p><strong>Methods: </strong>We retrospectively reviewed electronic medical record information of patients whose hemoglobin and serum FA/VB12 concentrations were measured at the Department of Hematology (N=1,388) and other departments (N=1,421) of Fujita Health University Hospital.</p><p><strong>Results: </strong>In the Hematology Department, 530 (38%) patients showed normocytic anemia. Of these, 49 (9.2%) had FA/VB12 deficiency. Twenty of 49 (41%) patients had some hematological malignancies and 27 (55%) had benign hematological disorders. Of the nine patients who received vitamin replacement therapy, one showed a partial improvement in the hemoglobin concentration of ≥1 g/dL.</p><p><strong>Conclusions: </strong>In the clinical setting, the measurement of FA/VB12 concentrations in patients with normocytic anemia may be useful. Replacement therapy may be a treatment option to consider in patients with low FA/VB12 concentrations. However, physicians need to pay attention to the presence of background diseases, and the mechanisms of this situation require further investigation.</p>\",\"PeriodicalId\":33657,\"journal\":{\"name\":\"Fujita Medical Journal\",\"volume\":\"9 2\",\"pages\":\"134-141\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206897/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fujita Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20407/fmj.2022-016\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fujita Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20407/fmj.2022-016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:叶酸(FA)和维生素B12 (VB12)缺乏是导致大细胞性贫血的原因。然而,在临床实践中,FA和/或VB12缺乏症可发生在正常细胞性贫血患者中。本研究旨在确定正常细胞性贫血患者FA/VB12缺乏症的患病率以及维生素替代治疗在这些患者中的重要性。方法:回顾性分析藤田保健大学医院血液科(N= 1388)和其他科室(N= 1421)检测血红蛋白和血清FA/VB12浓度的患者电子病历信息。结果:血液科有530例(38%)患者出现正红细胞性贫血。其中49例(9.2%)有FA/VB12缺乏症。49例患者中有20例(41%)有一些血液系统恶性肿瘤,27例(55%)有良性血液系统疾病。在接受维生素替代治疗的9例患者中,1例血红蛋白浓度≥1 g/dL部分改善。结论:在临床中,测定正红细胞性贫血患者的FA/VB12浓度可能是有用的。替代疗法可能是低FA/VB12浓度患者的一种治疗选择。然而,医生需要注意背景疾病的存在,这种情况的机制需要进一步调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Involvement of folate and vitamin B12 deficiency in patients with normocytic anemia.

Involvement of folate and vitamin B12 deficiency in patients with normocytic anemia.

Involvement of folate and vitamin B12 deficiency in patients with normocytic anemia.

Involvement of folate and vitamin B12 deficiency in patients with normocytic anemia.

Objectives: Deficiencies in folate (FA) and vitamin B12 (VB12) are causes of macrocytic anemia. However, in clinical practice, FA and/or VB12 deficiency can occur in patients with normocytic anemia. This study aimed to determine the prevalence of FA/VB12 deficiency in patients with normocytic anemia and the importance of vitamin replacement therapy in these patients.

Methods: We retrospectively reviewed electronic medical record information of patients whose hemoglobin and serum FA/VB12 concentrations were measured at the Department of Hematology (N=1,388) and other departments (N=1,421) of Fujita Health University Hospital.

Results: In the Hematology Department, 530 (38%) patients showed normocytic anemia. Of these, 49 (9.2%) had FA/VB12 deficiency. Twenty of 49 (41%) patients had some hematological malignancies and 27 (55%) had benign hematological disorders. Of the nine patients who received vitamin replacement therapy, one showed a partial improvement in the hemoglobin concentration of ≥1 g/dL.

Conclusions: In the clinical setting, the measurement of FA/VB12 concentrations in patients with normocytic anemia may be useful. Replacement therapy may be a treatment option to consider in patients with low FA/VB12 concentrations. However, physicians need to pay attention to the presence of background diseases, and the mechanisms of this situation require further investigation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
0
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信